Staging only. Nothing is live on the store's published theme.
Saffron and NAD+: real products, pages and homepage
Both are real Shopify products now (hidden from search, out of stock, each with its own collection and free-first-bottle plan). Tap to open the staging pages on cleanhealthlab.com (no login).
Saffron pagedeep umber and honey NAD+ pagenavy and ice blue Homepage with both productsnew hero, shop cards, "New in the line"Saffron, first three phone screens
NAD+, first three phone screens
Homepage, first three phone screens
Group shots
NAD+ photos (7 scenes, none shows a loose capsule: it is a size 00)
Blind scores
Blind page judge, three fresh runs, 12 supplement pages in the pool (judge-only in-stock presentation; the real page says Out of stock, which a judge scores as a failed buy path):
| Page | Mean | Overall by run |
|---|---|---|
| Live L-Methylfolate page | 8.17 | 9, 8, 8 |
| NAD+ | 7.72 | 8, 7, 8 |
| Saffron | 7.72 | 7, 8, 8 |
| Earlier Saffron lander | 7.56 | 8, 7, 7 |
| Seed | 7.55 | 7, 8, 8 |
| Ritual | 6.95 | 6, 7, 7 |
Copy reads (does it sound like a person, 1 to 10; Nutrafol page as the control, 2 to 4): Saffron 7, 8, 7, 6 and NAD+ 6, 7, 6, 6 across rounds (Claude and Astra). Both clear the control by 3 to 5 points. NAD+ sits a point under Saffron because it has to carry real study numbers, and I stopped chasing the last point.
Homepage, same blind pool as before (9 sites, 9 judges): new homepage 7.00 overall vs the live one 7.06, a tie. Looks 7.8 vs 7.4, first screen 8.9 vs 8.8, proof 7.4 vs 6.8, copy voice 7.75 (best of the nine) on both.
Doctors and studies
Every study was opened and checked on PubMed. Saffron: Akhondzadeh, Lopresti, Sarris, Berk, Marx and the trials on Prozac side effects. NAD+: Klein and Imai (Washington University), Seals (Colorado), Bhasin (Harvard), Lavery (Birmingham), with the compound named on every line, because almost all the human trials used NMN or NR and only one used oral NAD+ itself.
What I need from you
- Prices. Saffron $64.99, then $55.99 every 2 months (the 10-27 research pick). NAD+ $69.99, then $59.99 every month is my proposal: a 60-capsule bottle at $59.99 sits at the 75th percentile of 16 NAD+ listings (median $1.33 a day).
- The word "push" to put the two pages and the homepage on the live theme.
- Real stock, a lot report and a barcode for each, and the maker's yes on "3.5% standard" and "every lot tested". The NAD+ legal status as a US ingredient is still open.
Files: WebBuildr releases/chl-new-products-2026-10-28/RELEASE.md and AdMaker research/new-products-2026-10-28/.